Amarin faces revenue declines due to generic competition, with losses outpacing revenue. Explore challenges, risks, and M&A ...

Viatris Inc. (NASDAQ:VTRS) became the subject of a securities fraud class action lawsuit filed in the U.S. District Court for ...

ORLANDO, FL / ACCESS Newswire / June 6, 2025 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc.

Bio-Techne faces significant macro and policy headwinds, including reduced academic research funding, China risks, and U.S.

Nantahala Capital Management, Stonepine Capital Management, Aytu Management, and New Institutional Shareholders Lead Financing. DENVER, CO / ACCESS Newswire / June 6, 2025 / Aytu BioPharma, Inc. (the ...

Vera Therapeutics (NASDAQ:VERA) fell ~32% in the premarket on Friday after late-stage trial data indicated that the company’s ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc. (NASDAQ:SRPT) uses in its gene therapy ...

On June 4, analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Immix Biopharma, Inc. (NASDAQ:IMMX) with a ...

Avadel Pharmaceuticals (NASDAQ:AVDL) announced that its drug LUMRYZ (sodium oxybate) for extended-release oral suspension has ...

On June 4, Baird increased its price target for Agenus Inc. (NASDAQ: AGEN) to $6 from $4, while maintaining a Neutral rating ...

RadNet, Inc. (NASDAQ:RDNT) has moved to strengthen its prospects on the use of artificial intelligence to enhance ultrasound ...